Latest Breaking News On - Broad institute cas - Page 1 : vimarsana.com

Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of Reni-cel at the European Hematology Association 2024 Congress in June

Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of Reni-cel at the European Hematology Association 2024 Congress in June
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomHaydar frangoulHall velasquezCristi barnettRabi hannaBaisong meiEuropean hematology associationHarvard university casExchange commissionEditas medicine incEuropean hematology association congressDepartment of pediatric hematology oncologyBroad instituteBroad institute casPresent clinical data

Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting

Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomLindac burklyHarvard university casMeeting of the american society geneBroad instituteExchange commissionBroad institute casEditas medicine incAnnual meetingAmerican societyCell therapyChief scientific officerEditas medicineBased deliveryPotential treatment

Editas Medicine Announces First Quarter 2024 Results and Business Updates

Editas Medicine Announces First Quarter 2024 Results and Business Updates
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkUnited kingdomCristi barnettGregory whiteheadVivo hemoglobinopathiesEmmanuelle charpentierBristol myers squibbGilmore oneillLas vegasEditas medicine incBroad institute casUniversity of viennaVertex pharmaceuticals incorporatedGenetic medicines forumHarvard university cas

Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events

CAMBRIDGE, Mass., May 02, 2024 Editas Medicine, Inc. , a clinical-stage gene editing company, today announced that it will host a conference call and webcast on Wednesday, May 8, 2024, at 8:00.

United kingdomNew yorkUnited statesLas vegasHarvard university casBroad instituteGenetic medicines forumAmerica health care conferenceEditas medicine incBroad institute casEditas medicine earnings conferenceEditas medicineMarkets global healthcare conferenceAnnual genetic medicinesHarvard university

Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration

Two-year extension for research and development of alpha-beta T cell medicines for the treatment of cancer and autoimmune diseasesCAMBRIDGE, Mass., May 01, 2024 Editas Medicine, Inc. , a.

United kingdomCelgene bristol myers squibbBristol myers squibbLindac burklyBroad institute casExchange commissionEditas medicine incJuno therapeutics incHarvard university casBroad instituteMyers squibbChief scientificEditas medicineJuno therapeuticsHarvard universityPrivate securities litigation reform act